"10.1371_journal.pone.0022640","plos one","2011-07-25T00:00:00Z","Johan Svensson; Klara Sjögren; Jenny Fäldt; Niklas Andersson; Olle Isaksson; John-Olov Jansson; Claes Ohlsson","Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden; Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden; Food Science Unit, Department of Chemical and Biological Engineering, Chalmers University of Technology, Göteborg, Sweden","Conceived and designed the experiments: JS KS JF NA OI J-OJ CO. Performed the experiments: JS KS JF NA OI J-OJ CO. Analyzed the data: JS KS JF NA OI J-OJ CO. Contributed reagents/materials/analysis tools: JS KS JF NA OI J-OJ CO. Wrote the paper: JS KS JF NA OI J-OJ CO. All authors contributed to the design and performance of the experiments, analysis of data, and preparation of the manuscript.","Olle Isaksson was co-founder of Tercica Inc. that produced IGF-I for use in children of short stature. Tercica Inc. was acquired by Ipsen June 2008. Olle Isaksson has no current ownership of stocks or options in Tercica or Ipsen. None of the other authors has any conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","07","Johan Svensson","JS",7,TRUE,7,7,7,7,TRUE,TRUE,FALSE,0,NA,FALSE
